|
Market Closed -
Other stock markets
|
Pre-market 07:05:22 | |||
| 42.05 EUR | -0.17% |
|
41.82 | -0.55% |
| 07-16 | FMC FRESENIUS MEDICAL CARE AG : Gets a Neutral rating from Bernstein | ZD |
| 07-13 | European Equities Traded in US as ADRs Decline | MT |
Evolution of the Average Target: Fresenius Medical Care AG
Evolution of the Target Price: Fresenius Medical Care AG
Changes in Analyst Recommendations: Fresenius Medical Care AG
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +4.18% | |||||
| +5.09% | |||||
| +21.99% | |||||
| +29.62% | |||||
| +6.94% | |||||
| +23.56% | |||||
| +22.44% | |||||
| +33.86% | |||||
| -10.87% | |||||
| +6.56% | |||||
| Average | +14.34% | |||||
| Weighted average by Cap. | +13.43% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| BERNSTEIN RESEARCH | Susannah Ludwig |
| JPMORGAN | David Adlington |
| UBS | Graham Doyle |
| Goldman Sachs | |
| DZ BANK | Sven Kürten |
| JEFFERIES | James Vane-Tempest |
| BARCLAYS | Hassan Al-Wakeel |
| alphavalue | Jitisha Malhotra |
| DEUTSCHE BANK RESEARCH | Falko Friedrichs |
| Truist Securities | |
| BERENBERG | Sam England |
| MWB Research | |
| BNP Paribas Exane | |
| Morningstar | |
| WARBURG RESEARCH | Christian Ehmann |
| AlphaValue/Baader Europe | |
| M. M. Warburg & Co. | |
| Berenberg Bank | |
| MORGAN STANLEY | Robert Davies |
| HSBC | |
| CREDIT SUISSE | Christoph Gretler |
| Jefferies & Co. | |
| DEUTSCHE BANK | Falko Friedrichs |
| Oddo BHF | |
| STIFEL | Daniel Grigat |
| KEPLER CHEUVREUX | Oliver Reinberg |
| RBC Capital Markets | |
| NORDLB | Holger Fechner |
| INDEPENDENT RESEARCH | Tobias Gottschalt |
| RBC | Frank Morgan |
| BANK OF AMERICA (BOFA) |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FME Stock
- Consensus Fresenius Medical Care AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition